Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Facialderm is a Spanish dermocosmetics company that pioneered the concept of neurocosmetics, focusing on the connection between the nervous system and skin health. The company develops advanced skincare solutions designed to combat the physical effects of stress and high cortisol levels on the skin, such as premature aging and loss of elasticity. Their product portfolio features targeted serums and creams formulated with Neurophroline, an innovative active ingredient that inhibits local cortisol production in skin cells. Headquartered in Barcelona, Facialderm emphasizes personalized skincare through a modular system that allows users to combine different treatments based on their specific skin needs. The brand operates at the intersection of neuroscience and dermatology to provide high-performance consumer healthcare products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FACIALDERM.